Found "Vaccines": 76 results
Sort by
Relevance

How can we evaluate the potential of innovative vaccine products and technologies in resource constrained settings? A total systems effectiveness (TSE) approach to decision-making

Abstract Innovations in vaccine product attributes could play an important role in addressing coverage and equity (C&E) gaps, but there is currently a poor understanding of the full system impact and trade-offs associated with investing in such technologies, both from the perspective of natio

Preliminary recommendations on the establishment of a regional centre for infectious disease control in ASEAN

“United we stand, divided we fall” is a Thai idiom used to exemplify the importance of staying united and of teamwork and common interests. This idiom is reaffirmed in the context of the COVID-19 pandemic, shown in the global nature of catastrophe and the shared prospects of recovery. However, p

Bird Flu Paper Is Published After Debate

The more controversial of two papers describing how the lethal H5N1 bird flu could be made easier to spread was published Thursday, six months after a scientific advisory board suggested that the papers’ most potentially dangerous data be censored.The paper, by scientists at Erasmus Medical Center i

China Health Technology Assessment (HTA) Hub

The past few years have seen significant progress in the development of Health Technology Assessment (HTA) in China. The China National Health Development Research Center (CNHDRC), the national focal point for HTA in China, has stepped up efforts to roll out HTA activities in many ways in order to s

Using HTA to inform R&D: The Case of Total Systems Effectiveness

How do decision-makers in Thailand decide whether a new or improved vaccine should be added to the Expanded Program on Immunization (EPI)?What is the vaccine prioritization and selection processes in Thailand?How can the product preferences of low and middle-income countries (LMICS) be better commun

Beyond coverage decisions – Using HTA to link technology supply and population health demand

Policymakers across the world are regularly required to make crucial decisions about resource allocation and prioritize interventions – medicine A or medicine B, subsidize heart surgery or expand the immunization program. This process is required to be transparent, accountable a

Advancing Universal Health Coverage Through Health Technology Assessment (HTA) – A Perspective from Kerala

The 2019 National University of Singapore (NUS) Initiative to Improve Health in Asia Leadership Development Programme (NIHA LDP) was held at NUS, Singapore from the 24th – 29th June. The event aimed to equip policy-makers with an understanding of  health technology assessment (HTA) for health care p

China using Health Technology Assessment to guide healthcare policy making is the right direction!

Partners from the International Decision Support Initiative (iDSI) join the 2nd China Health Technology Assessment Conference organised by the China National Health Development Research Center (CNHDRC) on 26-27 October 2019 in Beijing, China. The event brings together China’s high-level representati

Vaccinology for Clinical and Public Health Practice: Policy Symposium and Workshop: From participant’s perspective

This blog has been jointly written by Dr. Phetsavanh Chanthavilay from the Institute of Research and Education Development, University of Health Sciences, Lao PDR, and Mr. Nantasit Luangasanatip from the Mahidol-Oxford Tropical Medicine Research Unit, Thailand. Their participation in this e

What the Role of HTA in Healthcare Systems should be after COVID-19?

The COVID-19 pandemic has transformed healthcare systems around the world. One of important issues that COVID-19 clearly emphasizes is the critical importance of information on health technology and policy. Handling the COVID-19 pandemic was difficult at the beginning because humanity all faced the
10 / Page